Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-06-26 @ 1:37 PM
Study NCT ID:
NCT06176560
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-19
First Post:
2023-12-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.
Sponsor:
Faes Farma, S.A.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Colitis, Ulcerative | View |
Keywords: